These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18698159)

  • 21. UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA.
    Abe S; Kubota T; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Jpn J Cancer Res; 2000 Nov; 91(11):1192-8. PubMed ID: 11092986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nifedipine synergizes with calcium in activating the calcium sensing receptor, suppressing the expression of thymidylate synthase and survivin and promoting sensitivity to fluorouracil in human colon carcinoma cells.
    Liu G; Hu X; Premkumar L; Chakrabarty S
    Mol Carcinog; 2011 Dec; 50(12):922-30. PubMed ID: 21374737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
    Hsueh CT; Kelsen D; Schwartz GK
    Clin Cancer Res; 1998 Sep; 4(9):2201-6. PubMed ID: 9748140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.
    Kirihara Y; Yamamoto W; Toge T; Nishiyama M
    Int J Oncol; 1999 Mar; 14(3):551-6. PubMed ID: 10024690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.
    Lee JH; Park JH; Jung Y; Kim JH; Jong HS; Kim TY; Bang YJ
    Mol Cancer Ther; 2006 Dec; 5(12):3085-95. PubMed ID: 17172411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel.
    Nief N; Le Morvan V; Robert J
    Eur J Cancer; 2007 Mar; 43(5):955-62. PubMed ID: 17317154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of the therapeutic efficacy of thymidylate synthase inhibitors.
    Peters GJ; Kuiper CM; van Triest B; Backus H; van der Wilt CL; van Laar JA; Jansen G; van Groeningen CJ; Pinedo HM
    Adv Exp Med Biol; 1998; 431():699-704. PubMed ID: 9598155
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytotoxins and cancer immunotherapy: the dance of the macabre?
    Allegra CJ; Childs RW
    J Natl Cancer Inst; 2005 Oct; 97(19):1396-7. PubMed ID: 16204684
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
    Ma T; Zhu ZG; Ji YB; Zhang Y; Yu YY; Liu BY; Yin HR; Lin YZ
    World J Gastroenterol; 2004 Jan; 10(2):172-6. PubMed ID: 14716816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The correlation between thymidylate synthase expression and cytotoxicity of 5-fluorouracil in human cancer cell lines: study using polyclonal antibody against recombinant human thymidylate synthase].
    Okabe H; Tsujimoto H; Fukushima M
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):705-12. PubMed ID: 9126308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
    Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
    Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors.
    Van Triest B; Pinedo HM; Giaccone G; Peters GJ
    Ann Oncol; 2000 Apr; 11(4):385-91. PubMed ID: 10847455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients.
    Marcuello E; Altés A; del Rio E; César A; Menoyo A; Baiget M
    Int J Cancer; 2004 Dec; 112(5):733-7. PubMed ID: 15386371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Difference in Ki67 and thymidylate synthase expression in primary tumour compared with metastatic nodes in breast cancer patients.
    Calascibetta A; Cabibi D; Rausa L; Aragona F; Barresi E; Martorana A; Sanguedolce R
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1193-6. PubMed ID: 17065089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomics of thymidylate synthase in cancer treatment.
    Danenberg PV
    Front Biosci; 2004 Sep; 9():2484-94. PubMed ID: 15353301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.
    Xi Y; Nakajima G; Schmitz JC; Chu E; Ju J
    BMC Genomics; 2006 Apr; 7():68. PubMed ID: 16584549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway.
    Jiang B; Liu F; Liu Z; Zhang T; Hua D
    Tumour Biol; 2016 Jul; 37(7):9465-72. PubMed ID: 26787540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratumoural thymidylate synthase and dihydropyrimidine dehydrogenase activities are good predictors of 5-fluorouracil sensitivity in colorectal cancer.
    Ishibiki Y; Kitajima M; Sakamoto K; Tomiki Y; Sakamoto S; Kamano T
    J Int Med Res; 2003; 31(3):181-7. PubMed ID: 12870370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of correlation between immunohistochemical expression of E2F-1, thymidylate synthase expression and clinical response to 5-fluorouracil in advanced colorectal cancer.
    Belvedere O; Puglisi F; Di Loreto C; Cataldi P; Guglielmi A; Aschele C; Sobrero A
    Ann Oncol; 2004 Jan; 15(1):55-8. PubMed ID: 14679120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
    Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.